Ms. Irene Ketseoglou

Irene Ketseoglou is a South African molecular scientist whose work bridges medical virology, tuberculosis diagnostics, and molecular hematology. Affiliated with research and diagnostic initiatives linked to major public health laboratories in Southern Africa, her scholarship reflects a strong focus on translating molecular tools into improved clinical and epidemiological practice.

Her research explores HIV drug resistance, viral tropism, and treatment failure, contributing to evidence that has informed pediatric antiretroviral guidelines. She has also characterized rifampicin-resistant Mycobacterium tuberculosis strains and examined laboratory scale-up strategies during the SARS-CoV-2 pandemic, highlighting expertise in high-throughput molecular diagnostics and public health laboratory systems.

More recently, her work has examined JAK2-mutated myeloproliferative neoplasms and rare prothrombotic mutations in African populations, addressing regional data gaps in hematologic malignancies and thrombophilia. Earlier contributions in vector control and genetically engineered cyanobacteria demonstrate interdisciplinary strength in biotechnology and infectious disease prevention.